北美过敏免疫疗法市场预测至 2027 年 - COVID-19 影响和治疗区域分析（皮下免疫疗法 (SCIT) 和舌下免疫疗法 (SLIT)）、过敏类型（过敏性鼻炎、哮喘、食物过敏、毒液过敏等）、分销渠道（医院药房、零售药房和在线药房）和地理位置
No. of Pages: 95 | Report Code: TIPRE00014185 | Category: Life Sciences
No. of Pages: 95 | Report Code: TIPRE00014185 | Category: Life Sciences
过敏原免疫治疗，也称为低敏或脱敏，是一种针对过敏症的医学治疗方法。向患者给予一定剂量的过敏原，从而减少炎症，从而通过阻断抗体功能，导致免疫系统对物质的敏感性降低。过敏免疫疗法的主要治疗目标包括减轻症状、减少对症药物的使用以及改善过敏相关的生活质量。
2019年北美过敏免疫治疗市场价值为6.9753亿美元，预计到2027年将达到16.3417亿美元；预计在预测期内复合年增长率为 11.3%。 这可以归因于该行业的研发活动导致医疗保健行业不断发展。各种研究机构和组织为改善医疗设施和服务而采取的越来越多的举措进一步推动了市场的增长。健康疾病的数量不断增加，以及对改进治疗和预防措施的需求不断增长，推动了医疗行业的技术进步。
根据治疗情况，SCIT 细分市场在北方占有较大份额2019 年美国过敏免疫疗法市场。然而，预计 SLIT 细分市场在预测期内将以更高的复合年增长率增长。根据过敏类型，过敏性鼻炎细分市场在 2019 年占据最大市场份额，预计在预测期内市场复合年增长率最高。
基于分销渠道中，医院药房设置细分市场占据最大份额2019年北美过敏免疫疗法市场，预计在预测期内将以最快的复合年增长率增长。
< strong>主要来源和上市公司
一些主要的一手和二手来源 北美过敏免疫疗法市场 报告中包含 美国过敏、哮喘和哮喘学会免疫学，Celsion Corporation， 美国食品和药物管理局 (FDA) 和世界过敏组织 (WAO)。
< /span>
北美过敏免疫疗法市场 -通过治疗
北美过敏免疫疗法市场 -按过敏类型
北美过敏免疫疗法市场 –通过分销渠道
北美过敏免疫疗法市场 -按地理位置
公司简介
Strategic insights for North America Allergy Immunotherapies involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 697.53 Million |
| Market Size by 2027 | US$ 1,634.17 Million |
| Global CAGR (2019 - 2027) | 11.3 % |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By 治疗
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Allergy Immunotherapies refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Allergy Immunotherapies Market is valued at US$ 697.53 Million in 2019, it is projected to reach US$ 1,634.17 Million by 2027.
As per our report North America Allergy Immunotherapies Market, the market size is valued at US$ 697.53 Million in 2019, projecting it to reach US$ 1,634.17 Million by 2027. This translates to a CAGR of approximately 11.3 % during the forecast period.
The North America Allergy Immunotherapies Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Allergy Immunotherapies Market report:
The North America Allergy Immunotherapies Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Allergy Immunotherapies Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Allergy Immunotherapies Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Allergy Immunotherapies Market
